More than SEK 31 million from the Erling-Persson Foundation
Vaccination strategies against pneumococci, cardiovascular research with magnetic camera and an atlas over human cells – these are some of the research projects related to Karolinska Institutet that the Erling-Persson Family Foundation has chosen to support in 2018. More than SEK 31 million goes to four projects led by KI. In addition, KI researchers are included in another project led by KTH Royal Institute of Technology.
The Erling-Persson Family Foundation mainly funds research in medicine and healthcare. Important selection criteria for the funding programme are that the research is translational, application oriented, and involves interdisciplinary cooperation.
This year's grantees at KI:
Principal investigator: Birgitta Henriques Normark, Department of Microbiology, Tumor and Cell Biology
Topic: Developing membrane particles for a vaccination strategy with broader effect than present ones against pneumococcal infections
Grant: SEK 9 million over 3 years
Principal investigator: Anders Björkman, Department of Microbiology, Tumor and Cell Biology
Topic: Malaria control at Zanzibar, Tanzania
Grant: SEK 2 million, one year.
Principal investigator: Stefan Carlsson, Department of Molecular Medicine and Surgery
Topic: Treatment against prostate cancer – PSMA/PET controlled treatment compared to conventional radiation therapy, a randomized study.
Grant: SEK 7.5 million over 3 years (the study will be carried out at Cancer Center Karolinska).
Principal investigator: Lars Rydén, Department of Medicine, Solna
Topic: Cardiovascular research with magnetic camera, MR Thorax
Grant: SEK 12.7 million over 3 years.
Principal investigator (co-applicant): Sten Linnarsson, Department of Medical Biochemistry and Biophysics
Main applicant: Joakim Lundeberg, KTH
Topic: The Human Developmental Cell Atlas
Grant: SEK 60 million over 4 years (for the entire project).